Horizon Kinetics Asset Management LLC Gilead Sciences, Inc. Transaction History

Horizon Kinetics Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $2,440 - $2,662	-33 Reduced 0.37%	9,000 $674,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2,508 - $2,861	33 Added 0.37%	9,033 $696,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $116,824 - $146,393	-2,017 Reduced 18.31%	9,000 $535,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $50,985 - $58,095	-900 Reduced 7.55%	11,017 $642,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1,229 - $1,428	17 Added 0.14%	11,917 $917,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $56,367 - $72,198	900 Added 8.18%	11,900 $890,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $12,502 - $13,800	-200 Reduced 1.79%	11,000 $697,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $74,244 - $83,256	1,200 Added 12.0%	11,200 $757,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $625,300 - $700,500	10,000 New	10,000 $650,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.